GSK declares positive results from phase III trial for Blenrep in relapsed/ refractory multiple myeloma Ruchika Sharma28 Nov 2023 12:30 PM ISTLondon: GSK plc has announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial...
US FDA to delay decision on Bristol Myers-2seventy bio cancer therapy Ruchika Sharma21 Nov 2023 2:30 PM ISTThe therapy was originally co-developed by bluebird bio but following its spin-off in 2021 became part of 2seventy's portfolio.
EU medicines regulator recommends conditional marketing nod for Pfizer blood cancer therapy Ruchika Sharma15 Oct 2023 2:15 PM ISTNew York: The European Union medicines regulator has recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type...
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
Pfizer Elrexfio bags USFDA accelerated nod for multiple myeloma treatment Ruchika Sharma16 Aug 2023 11:41 AM ISTNew York: Pfizer Inc. has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to ELREXFIO (elranatamab-bcmm) for...
Johnson and Johnson gets USFDA accelerated nod for multiple myeloma drug Talvey Ruchika Sharma11 Aug 2023 11:29 AM ISTTALVEY is approved as a weekly or biweekly subcutaneous (SC) injection after an initial step-up phase, offering physicians the flexibility to...
Zydus Lifesciences bags USFDA nod for Plerixafor Injection Ruchika Sharma27 July 2023 3:25 PM ISTAhmedabad: Zydus Lifesciences Limited has announced that the company has received final approval from the United States Food and Drug...
Aurobindo Pharma arm bags USFDA nod for Plerixafor Injection Ruchika Sharma25 July 2023 3:55 PM ISTPlerixafor injection is indicated in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells (HSCs) to the...
J&J Gets CDSCO Panel Nod To Market Teclistamab sterile liquid in Vials Dr. Divya Colin7 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under...
Multiple Myeloma: A Comprehensive Guide To The Disease - Dr Ushang Kate Dr Ushang Kate10 Jun 2023 12:39 PM ISTMultiple myeloma (MM) is a relatively rare form of cancer, accounting for approximately 1% of all cancers and 10% of all haematological...
Janssen seeks USFDA nod for Carvykti for relapsed or refractory multiple myeloma Ruchika Sharma8 Jun 2023 12:30 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License...
